Management of Melasma using Synthesis Repertory
Phase 3
- Conditions
- Health Condition 1: L811- Chloasma
- Registration Number
- CTRI/2024/04/065204
- Lead Sponsor
- Dr Nitisha Manoj Bhartiya
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients with the complaints of melasma assessed by MSI and MelasQol scales will be inculded.Patients aged 25 years and above will be included.Those who are willing to participate and give consent.
Exclusion Criteria
Patients having co-morbididties like Thyroid,PCOD and Melanoma (CA of skin).Patients having other dermatological co-morbidities like Dermatoses,Roscea,Vitiligo,Psoriasis.Patients exposed to previous intervention like chemical peeling , laser or any topical steroid mixed cream in last 6 months.Patients who were taking any oral or topical medications for melasma.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To study and prescribe homoeopathic medicines for melasma by using synthesis repertory as a tool of study.Timepoint: To study and prescribe Homoeopathic medicines in cases of melasma by using synthesis repertory as a tool of study.Every follow up will be taken after 10-15 days for 3 months.
- Secondary Outcome Measures
Name Time Method To find out the effectiveness of Homoeopathic medicines by using synthesis repertory in cases of melasma.Timepoint: The follow up taken for 3 months will be used assess effectiveness of Homoeopathic medicines by using synthesis repertory in cases of melasma. The case will be assessed by MSI & MelasQol scales before & after treatment.